IMMUNE-RELATED ADVERSE EVENT
Clinical trials for IMMUNE-RELATED ADVERSE EVENT explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-RELATED ADVERSE EVENT trials appear
Sign up with your email to follow new studies for IMMUNE-RELATED ADVERSE EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Asthma inhaler tested to tame dangerous side effect of cancer treatment
Disease control Recruiting nowThis study is testing if using an inhaled steroid (like those for asthma) for one year can help prevent lung inflammation from coming back in cancer patients. The inflammation is a serious side effect of powerful immunotherapy drugs. The goal is to control this side effect with f…
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New approach aims to tame painful arthritis side effect of cancer drugs
Disease control Recruiting nowThis study is testing if starting a drug called adalimumab early can better control a painful arthritis that sometimes develops as a side effect of powerful cancer immunotherapy drugs. The main goal is to see if this approach helps patients reduce or stop their use of steroid med…
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Phase: PHASE2 • Sponsor: Tom Appleton • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC